-

Owens & Minor to Participate in the UBS Global Healthcare Conference 2022 Monday, May 23, 2022

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) announced today that executive management will present at the UBS Global Healthcare Conference on Monday, May 23rd at 11:30 AM ET.

A live webcast and replay may be accessed at www.owens-minor.com under the investor relations section at investors.owens-minor.com/events-presentations/. Please visit Owens & Minor's website approximately 5-10 minutes prior to the presentation to register.

About Owens & Minor

Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company integrating product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. Owens & Minor drives visibility, control and efficiency for patients, providers and healthcare professionals across the supply chain with proprietary technology and solutions, an extensive product portfolio and an Americas-based manufacturing footprint for personal protective equipment (PPE) and surgical products, as well as a robust portfolio of products and services for patients managing chronic and acute conditions in the home setting. Operating continuously since 1882 from its headquarters in Richmond, Va., Owens & Minor is a 140-year-old company powered by more than 20,000 global teammates. Learn more at https://www.owens-minor.com, follow @Owens_Minor on Twitter and connect on LinkedIn at www.linkedin.com/company/owens-&-minor.

Contacts

Alex Jost, CPA
Director, Investor Relations
Investor.Relations@owens-minor.com

Industry:

Owens & Minor, Inc.

NYSE:OMI
Release Summary
Owens & Minor to Participate in the UBS Global Healthcare Conference 2022 on Monday, May 23, 2022
Release Versions
English

Contacts

Alex Jost, CPA
Director, Investor Relations
Investor.Relations@owens-minor.com

More News From Owens & Minor, Inc.

Accendra Health Reports Fourth Quarter 2025 Financial Results

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. “We ended the fourth quarter with the completion of the sale of the Products & Healthcare Services (P&HS) business on December 31, 2025, and we are...

Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the fourth quarter of 2025 on Thursday, February 19, 2026, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EST on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 105...

Accendra Health, Inc. to Begin Trading on NYSE under New Ticker “ACH”

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) announced that the Company’s common stock will begin trading on the New York Stock Exchange under its new ticker symbol, “ACH”, effective today. The Company also announced the launch of its new website, www.accendrahealth.com. On December 31, 2025, the Company announced the completion of the sale of its former Products & Healthcare Services business along with the Owens & Minor brand. Safe Harbor This rele...
Back to Newsroom